KMX
61
-3
SHW
64
2
BSX
73
2
CCL
47
6
ORCL
67
2
IVZ
65
3
OMC
66
-2
TEL
88
5
MSI
54
2
HP
32
-2
AN
61
-2
ADBE
49
4
K
45
-3
MAC
75
-4
CMA
56
4
ICE
69
3
GWW
64
6
AAPL
55
2
VRSK
75
-2
THC
79
2
KMX
61
-3
SHW
64
2
BSX
73
2
CCL
47
6
ORCL
67
2
IVZ
65
3
OMC
66
-2
TEL
88
5
MSI
54
2
HP
32
-2
AN
61
-2
ADBE
49
4
K
45
-3
MAC
75
-4
CMA
56
4
ICE
69
3
GWW
64
6
AAPL
55
2
VRSK
75
-2
THC
79
2
Financhill
Back

Agilent Technologies Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
58

A
Agilent Technologies

Last Price:
154.37
Seasonality Move:
-2.86%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
42.60
Seasonality Move:
12.29%
Buy
58
Agilent Technologies (A) is a Buy

Is Agilent Technologies a Buy, Sell or Hold?

  • The current Agilent Technologies [A] share price is $154.08. The Score for A is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • A is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $41.12. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

A Stock Price Chart

What is Agilent Technologies's stock price today?

  • The Agilent Technologies share price today is $154.08
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and A is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $41.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

A Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.59 Buy
Relative Strength Index (14 RSI): 70.14 Buy
Chaikin Money Flow: 822075 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (134.95 - 146.03) Buy
Bollinger Bands (100): (132.12 - 145.06) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.38 Sell
Relative Strength Index (14 RSI): 36.17 Sell
Chaikin Money Flow: -526969 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.16 - 45.34) Sell
Bollinger Bands (100): (43.31 - 49.39) Sell

A Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 146.59 Buy
20-day SMA: 140.74 Buy
50-day SMA: 143.32 Buy
200-day SMA: 128.12 Buy
8-day EMA: 147.57 Buy
20-day EMA: 143.7 Buy
50-day EMA: 141.43 Buy
200-day EMA: 133.61 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.46 Sell
20-day SMA: 42.72 Sell
50-day SMA: 45.61 Sell
200-day SMA: 42.06 Sell
8-day EMA: 41.51 Sell
20-day EMA: 42.79 Sell
50-day EMA: 44.59 Sell
200-day EMA: 44.26 Sell

Agilent Technologies Earnings Growth & A Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.09 per share, and an increase next year of $0.60 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.08 per share, an increase this year of $0.87 per share, and an increase next year of $1.24 per share.

Agilent Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):